Table 6. Age differences in change in EPA and DHA in plasma fractions, cells and AT following 12-months supplementation with EPA + DHA.
| EPA | DHA | |||||
|---|---|---|---|---|---|---|
| Middle vs. Young1 | Old vs. Young1 | P 2 | Middle vs. Young1 | Old vs. Young1 | P 2 | |
| Plasma PC | 0.27 [−0.10, 0.64] | 0.14 [−0.23, 0.51] | 0.35 | 0.30 [−0.28, 0.87] | 0.22 [−0.35, 0.79] | 0.59 |
| Plasma CE | 0.14 [−0.20, 0.47] | 0.28 [−0.06, 0.61] | 0.26 | 0.05 [−0.07, 0.17] | 0.00 [−0.12, 0.12] | 0.68 |
| Plasma NEFA | 0.25 [0.04, 0.47] | 0.19 [−0.02, 0.41] | 0.07 | 0.20 [−0.37, 0.76] | 0.09 [−0.47, 0.66] | 0.79 |
| Plasma TAG | 0.42 [0.05, 0.78] | −0.05 [−0.42, 0.32] | 0.02 | 0.15 [−0.28, 0.59] | −0.20 [−0.64, 0.23] | 0.23 |
| MNC | −0.01 [−0.34, 0.32] | −0.18 [−0.51, 0.15] | 0.46 | 0.09 [−0.22, 0.41] | −0.01 [−0.33, 0.31] | 0.76 |
| RBC | −0.46 [−1.56, 0.64] | −0.96 [−2.06, 0.14] | 0.23 | 0.14 [−0.53, 0.81] | −0.06 [−0.74, 0.61] | 0.82 |
| PLAT | 0.40 [0.05, 0.75] | 0.13 [−0.22, 0.47] | 0.07 | 0.13 [−0.12, 0.37] | −0.01 [−0.26, 0.24] | 0.45 |
| BU | 1.89 [−0.49, 4.27] | 1.45 [−0.92, 3.82] | 0.28 | −0.02 [−0.24, 0.21] | −0.19 [−0.42, 0.03] | 0.16 |
| AT | 0.00 [−0.05, 0.05] | −0.01 [−0.06, 0.04] | 0.91 | −0.03 [−0.09, 0.03] | −0.08 [−0.14, −0.02] | 0.02 |
Data are mean difference [95% CI] in the change in EPA or DHA expressed as percentage of total fatty acids between different age categories, adjusted for treatment group, compliance and BMI.
Analysis is change regressed on Middle vs. Young and Old vs. Young with a global test for age group presented, adjusted for treatment group, compliance and BMI.